Search for: "Novartis Pharmaceuticals Corporation" Results 101 - 120 of 155
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Sep 2011, 11:04 am by Tom Lamb
.; RECLAST (zoledronic acid) injection, Novartis Pharmaceuticals Corporation; and, the generic equivalents for these products, if any. [read post]
11 Jul 2011, 4:47 pm by FDABlog HPM
Kudos to The RPM Report team, which took note of some statements made during a recent meeting of FDA’s Arthritis Drugs Advisory Committee to discuss Novartis Pharmaceuticals Corporation’s (“Novartis’”) supplemental Biologics License Application (“sBLA”) for ILARIS (canakinumab) for the treatment of gouty arthritis attacks in certain patients.  [read post]
30 May 2011, 7:34 am by Steve McConnell
Novartis Pharmaceuticals Corp., No. 06-Civ-260 (BMC) (EDNY), and we’ve got some good news to report. [read post]
18 Apr 2011, 5:51 pm by FDABlog HPM
Prior to joining HP&M, Linda served in several pharmaceutical industry positions, including as Senior Director, Global Regulatory Policy and Intelligence, Janssen Pharmaceutical Companies of Johnson & Johnson, Executive Director, FDA Liaison, Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation, and Director, Global Regulatory Affairs, Legislative Policy and Regulatory Liaison, Pharmacia Corporation.  [read post]
26 Mar 2011, 10:17 am
It is another in a spate of gender discrimination lawsuits filed recently against large corporations: last Monday a class action lawsuit was filed against Bayer HealthCare Pharmaceuticals and its parent, Bayer Corp., both U.S. units of Bayer AG, alleging the company has engaged in various discriminatory behaviors against its female employees. (1) The lawsuit, filed in U.S. [read post]
17 Feb 2011, 1:59 pm by AALRR
SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals.  [read post]
15 Feb 2011, 4:06 am by Andrew Frisch
Unlike conventional retail sales, the patient is not at liberty to choose personally which prescription pharmaceutical he desires. [read post]
5 Jan 2011, 9:22 am by Gerald L. Maatman, Jr.
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010.  [read post]
17 Nov 2010, 3:48 pm by Mark Zamora
On March 20, 2009, after "much pain and intense suffering and massive infection," Plaintiff had the Device removed.[4] [Plaintiff's Complaint, Doc. 1-1, ¶ IX, at 7].Plaintiff has filed product liability claims against Boston Scientific and Advanced Bionics, the corporations which allegedly "designed, manufactured, assembled, distributed and sold" the Device. [read post]
5 Oct 2010, 8:48 am by fraudfighters
Department of Justice announced that it had reached an agreement with Novartis Pharmaceuticals Corporation in which the company agreed to pay $237.5 million to settle four False Claims Act lawsuits alleging that Novartis engaged in an unlawful off-label marketing scheme in connection with its anti-epileptic drug Trileptal and wrongfully paid kickbacks to physicians to encourage them to prescribe Trileptal, as well as other Novartis drugs.  [read post]
1 Oct 2010, 7:48 am by The Health Law Partners
Novartis Pharmaceuticals, a US subsidiary of a Swiss pharmaceutical group Novartis, settled with the US Department of Justice (DOJ) for $420 million for allegations of the off-label promotion of Trileptal, submitting false claims because of the unlawful marketing, and paying kickbacks to health care professionals inducing them to prescribe Trileptal and five other drugs. [read post]
1 Oct 2010, 5:35 am by David G. Badertscher
Attorney Zane Memeger said Novartis Pharmaceuticals has agreed to pay a criminal fine and forfeiture of $185 million, and also agreed to pay $237.5 million to resolve civil liabilities for its off-label marketing of six drugs.U.K. [read post]
30 Sep 2010, 5:03 am by Ben Vernia
Right on schedule to end the fiscal year, DOJ announced on September 30 that Novartis Pharmaceuticals Corp. has agreed to plead guilty to a misdemeanor and pay criminal and civil fines and damages. [read post]
27 Sep 2010, 12:59 am by FDABlog HPM
Karst –    Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]